May Measurement Month 2018: an analysis of blood pressure screening results from Nigeria.

Blood pressure Control Hypertension Nigeria Screening Treatment

Journal

European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647

Informations de publication

Date de publication:
Aug 2020
Historique:
entrez: 5 9 2020
pubmed: 5 9 2020
medline: 5 9 2020
Statut: ppublish

Résumé

Hypertension remains the dominant cardiovascular risk factor worldwide. May Measurement Month (MMM) is an annual global programme of the International Society of Hypertension aimed at screening for undetected hypertension in the general population. We report the outcome of MMM 2018 in Nigeria. An opportunistic screening of adults aged at least 18 years was conducted in the six geopolitical zones of Nigeria in the month of May, 2018. Screening for hypertension was done by trained volunteers with the use of validated digital and mercury sphygmomanometers following the MMM protocol. Hypertension was defined as blood pressure (BP) ≥140/90 mmHg or the use of BP-lowering medication. There were 6398 participants (53.0% female) with a mean (SD) age of 41.7 (15.0) years. Hypertension was present in 36.4% of the participants with 51.1% of the hypertensives aware of their status, 41.8% on medication, of whom 43.1% were controlled. Overall, only 18.0% of all hypertensive participants had their BP under control. The proportion with hypertension is high, and awareness, treatment, and control rates are low. Concerted efforts are needed to improve awareness and treatment of hypertension in Nigeria in order to reduce the high rate of complications associated with uncontrolled BP.

Identifiants

pubmed: 32884483
doi: 10.1093/eurheartj/suaa038
pii: suaa038
pmc: PMC7455261
doi:

Types de publication

Journal Article

Langues

eng

Pagination

H96-H99

Informations de copyright

Published on behalf of the European Society of Cardiology. © The Author(s) 2020.

Références

Stroke. 2018 May;49(5):1116-1122
pubmed: 29618553
J Stroke Cerebrovasc Dis. 2017 Jun;26(6):1222-1227
pubmed: 28189571
Int J Gen Med. 2014 Jul 03;7:345-53
pubmed: 25061335
Eur Heart J. 2019 Jul 1;40(25):2006-2017
pubmed: 31041440
BMC Cardiovasc Disord. 2018 Feb 7;18(1):26
pubmed: 29415657
J Hypertens. 2015 Feb;33(2):230-42
pubmed: 25380154
Lancet Glob Health. 2018 Apr;6(4):e436-e446
pubmed: 29496511
Eur Heart J Suppl. 2019 Apr;21(Suppl D):D86-D88
pubmed: 31043888

Auteurs

Kolawole W Wahab (KW)

Department of Medicine, University of Ilorin, Old Jebba Road, Ilorin 240003, Nigeria.

Philip M Kolo (PM)

Department of Medicine, University of Ilorin, Old Jebba Road, Ilorin 240003, Nigeria.

Mahmoud U Sani (MU)

Department of Medicine, Bayero University, BUK New Site, Kano 700241, Nigeria.

Njide U Okubadejo (NU)

Department of Medicine, University of Lagos, Idi Araba, Lagos 100254, Nigeria.

Johnson O Peter (JO)

Department of Medicine, Ladoke Akintola University of Technology, Isale Osun, Osogbo 230231, Nigeria.

Fred Aigbe (F)

Department of Medicine, Niger Delta University Teaching Hospital, Oghara via Sapele, Oghara 331101, Nigeria.

Muhammad A Makusidi (MA)

Department of Medicine, Usmanu Dan Fodiyo University, Gawo Nama, Sokoto 840232, Nigeria.

Akinyemi Aje (A)

Department of Medicine, University College Hospital, Queen Elizabeth Road, Ibadan 200212, Nigeria.

Arimiyau Adewale (A)

Department of Medicine, Federal Medical Centre, 1 Salihu Ibrahim Way, Lokoja 260101, Nigeria.

Phillip Adebola (P)

Department of Medicine, Lagos State University College of Medicine, 1-5 Oba Akinjobi Way, Ikeja 100001, Nigeria.

Thomas Beaney (T)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Department of Primary Care and Public Health, Imperial College London, St Dunstan's Road, London W6 8RP, UK.

Anca Chis Ster (AC)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Neil R Poulter (NR)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Xin Xia (X)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Ayodele B Omotoso (AB)

Department of Medicine, University of Ilorin, Old Jebba Road, Ilorin 240003, Nigeria.

Classifications MeSH